Skip to main content
# Title Research Member Research Year
221 Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment Prof. Ashraf Zeidan Abdalla Ahmed 2014
222 Outcome of young age at diagnosis of breast cancer in South Egypt Dr. Amen Hamdy Zaki Ali 2014
223 Management of Hot Flushes in Breast Cancer
Survivors: Comparison Between Stellate
Ganglion Block and Pregabalin
Dr. Amen Hamdy Zaki Ali 2014
224 The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant) Chemotherapy and its Impact as a Prognostic Factor in Early Breast Prof. Ashraf Zeidan Abdalla Ahmed 2014
225 ECF with Infusional Fluorouracil for 5 Days in Locally Advanced and Metastatic Gastric Cancer, Is It Better than the Standard?

Dr. Adel Gomaa Mohamed Gabr 2013
226 ECF with Infusional Fluorouracil for 5 Days in Locally Advanced and Metastatic Gastric Cancer, Is It Better than the Standard?

Dr. Abeer Elsayed Ali Ibrahim 2013
227 ECF with Infusional Fluorouracil for 5 Days in Locally Advanced and Metastatic Gastric Cancer, Is It Better than the Standard? Dr. Adel Gomaa Mohamed Gabr 2013
228 Prognostic value of regulatory T cells in newly diagnosed
chronic myeloid leukemia patients
Dr. Abeer Elsayed Ali Ibrahim 2013
229 Sphincter Saving Surgeries for Locally Advanced Low Rectal Cancer after Neoadjuvant Chemoradiation Dr. Abeer Elsayed Ali Ibrahim 2013
230 ECF with Infusional Fluorouracil for 5 Days in Locally Advanced and Metastatic Gastric Cancer, Is It Better than the Standard? Dr. Ahmed Mubarak Hefni Ismail 2013